"Right Ventricular Outflow Tract Posterior Septum Pacing" in Predicting Ventricular Outflow Tract Ventricular Tachycardia Origin
Key facts
- Who runs it
- Second Affiliated Hospital of Wenzhou Medical University
- Where
- China1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- People taking part
- 109 people enrolled
- Started
- 1 Apr 2023
- Ended
- 1 May 2025
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Right Ventricular Outflow Tract Posterior Septum Pacing
- systemic mapping and ablation
- Record updated
- 28 April 2026
Who can take part
- Age
- 18 years to 90 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 9 criteriaShow less
Who can take part
- Sign informed consent form
- Age more than 18 years old
- Able to understand the purpose of the experiment, voluntarily participate, willing to complete follow-up according to the requirement of the experimental protocol
Who cannot take part
- Severe cardiopulmonary, liver and kidney dysfunction, and inability to tolerate surgery due to coagulation dysfunction
- Viral myocarditis, myocardial infarction or stroke with a course of less than six months
- Simultaneously accompanied by malignant tumours, with an expected lifespan of less than or equal to 1 year
- Advanced age (more than 90 years old)
- Severe thoracic deformity
- Other situations that the researcher deems unsuitable for participation in the study
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
The goal of this clinical trial is to make clear that a new method, right ventricular outflow tract (RVOT) posterior septum pacing, has a greater accuracy in predicting the origin of ventricular outflow tract (VOT) ventricular arrhythmias (VAs) compared to the previous electrocardiographic standards for the identification of the origin of ventricular outflow tract. The secondary aim is to investigate, by using the new method, if it can optimize the procedure of radiofrequency catheter ablation.
Read full original descriptionShow less
Researches will break the method of this investigation into two steps:
First step have enrolled 100 patients. This step would be used to compare the results predicted by right ventricular outflow tract posterior septum pacing, with the previously used electrocardiographic criteria and actual target site.
The second step will enroll another 100 patients. In this step, patients will be divided into two groups, one being the new protocol group and the other being the convention group. Patients will also be followed up, for 1 month and 3 months at outpatient clinic post procedure. Procedure time, success rate, fluoroscopy exposure time and complications, are compared between RVOT posterior septum pacing group and convention group.
The 2 groups in the trial
- Right Ventricular Outflow Tract (RVOT) Posterior Septum Pacing GroupExisting treatment, for comparison
Treatment: Right Ventricular Outflow Tract Posterior Septum Pacing
- Convention GroupExisting treatment, for comparison
Treatment: systemic mapping and ablation
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- "Right Ventricular Outflow Tract Posterior Septum Pacing" in Predicting Ventricular Outflow Tract Ventricular Tachycardia Origin: a Single-center, Prospective, Single Blind, Randomised Controlled Study
- Record updated
- 28 April 2026